Cold Chain System
The cold-chain system is a necessity to maintain vaccine temperature stability - ensuring its effectiveness, safety, efficacy, and quality, which in turn provides its recipients with satisfactory protection against various infectious diseases.
Vaccine is a biotechnological product requiring careful handling in its distribution. The cold-chain system is system of distribution where vaccines are temperature-controlled since its dispatch from the plant, during distribution, in storage at destination,and before use.
Vaccines against BCG, DTP, TT, DT, Td, DTP-HB-Hib, measles, Hepatitis B, and influenza are temperaturecontrolled between 2 - 8°C while polio vaccines are temperature-controlled at -20°C.
Distribusi Vaksin Sektor
Vaccines are pharmaceutical products that could not be sold freely, for domestic vaccines. Bio Farma uses distribution channels for the public and private sectors. Vaccines for the public sector are sent directly through the provincial health office. Vaccines for the private sector are distributed through Pharmaceutical Wholesalers (PBF) who are registered with the POM agency. The names of Bio Farma's product distributors (PBF) as follows.
LIST OF COUNTRIES FOR BIO FARMA VACCINES DISTRIBUTION
Bio Farma's Contribution in the World
For more than 128 years, Bio Farma has contributed to improving the quality of life of the nation in Indonesia and the world. We have met the needs of national vaccines and world vaccine needs through WHO and UNICEF.
With the Dedicated to Improve Quality of Life philosophy, we play an active role in increasing the availability and independence of vaccine production in developing and Islamic countries to maintain global health security.
BIO FARMA’S FIRST VACCINE EXPORT TO SOUTH ASIA AND THE AMERICAS
On October 31, 2018, Bio Farma shipped its first vaccine exports to a number of countries. The vaccines were exported to four countries, two of which are in South Asia, i.e. Pakistan and India, one to Turkey, and the last shipment to Honduras in Central America.
The shipments were the first exports to those countries. Three of the shipments to Pakistan and Turkey were finished vaccines for polio (bOPV-20 doses) while Honduras received the diphteria-tetanus-pertussis (DTP) 10 doses. India received intermediate bulk product for polio vaccines. The total export value was US$5.18 million (about Rp75 billion), consisting of 50 million bulk dosages for polio to India and 1 million vials of bOPV-20 dosages and 10 dosages to Pakistan, Turkey, and Honduras.